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Urinary N-Acetyl-β-D-Glucosaminidase Excretion
in Asphyctic Newborns-Does it Predict the
Development of Acute Renal Failure?

Abstract:
Urinary
N-acetyl-β-Dglucosaminidase (NAG) levels of twenty
healthy full-term newborns and of seventeen
full-term newborns with perinatal asphyxia
were evaluated within the first 48 hours of
life. Urinary NAG levels and NAG indices (urinary NAG/urinary creatinine ratio) were significantly higher in newborns with perinatal
asphyxia than control group (p<0.001). Four
patients who developed an acute renal failure
(ARF) had higher urinary NAG levels; but this

Introduction
Perinatal asphyxia is the major cause of acute renal
failure (ARF) in neonates. The renal proximal tubules
have a high metabolic activity and are extremely sensitive to hypoxia (1,2). Renal function deteriorates in a
spectrum from mild tubular dysfunction to acute tubular necrosis depending on the severity of hpoxic insult. It is essential to evaluate renal function at an
early stage to stabilize fluid and electrolyte balance
which is of great importance to infants with hypoxicischemic encephalopathy (3). Yet, it is not quite easy
to evaluate neonatal renal function accurately. First of
all, 7% of healthy neonates may urinate as late as the
second day of life and non-oliguric ARF is not uncommon during neonatal period. Secondly, serum BUN
and creatinine levels determined during the first 24
hours of life reflect the maternal levels not those of
the neonate and also increased levels of serum bilirubin and piruvic acid in sick neonates may cuse deviation in colorimetric assessment of serum creatinine
level. Lastly, fractional sodium excretion (FeNa) which
is an important parameter to differentiate prerenal
and renal ARF should be cautiously interpreted in prematures, and in neonates receiving diuretics, aminophyline and intravenous fluid with high sodium content
(2-4).
Renal proximal tubular cells are rich in N-acetyl-βD glucosaminidase (NAG) which is one of lysosomal

increase was not found to be significant comparing to the NAG enzymuria in 13 other asphyctic newborns with normal renal functions. It is concluded that NAG enzymuria is
an early sensitive indicator of proximal renal
tubular damage and perinatal asphyxia but it
does not predict the further deterioration in
renal functions and the development of ARF.
Key Words: perinatal asphyxia, urine, kidney,
N-acetyl-b-D-glucosamindase

glucosidases. It has been shown that an injury to
proximal tubular cells for whatever reason causes high
urinary concentrations of this enzyme (enzymuria) (5).
We planned a study in neonates surviving perinatal
asphyxia by measuring urinary excretion of NAG. The
aim of this study was to determine the deleterious effect to proximal tubular cells and whether enzymuria
correlates with perinatal asphyxia.
Patients and Method
Seventeen full-term infants (10 males, 7 females)
born at 38-41 weeks of gestational age admitted to
the Neonatal Intensive Care Unit of Ege University
Medical School, Department of Pediatrics were included in this study. The criterion for perinatal asphyxia was one or more of the following –5 minute
Apgar score, lower than 5- intrauterine severe bradycardia-deterioration of biophysical profile-need of delivery room cardiopulmonary resuscitation –postnatal
documented metabolic acidosis (pH<7.25) and meconium stainig –elevated lactate dehydrogenase, brainmyocardium isoenzyme of creatine phosphokinase
(CPK-MB) which are considered markers for perinatal
asphyxia (6,7).
Premature infants were excluded since nephrogenesis is not completed before 35th week of gestation.
Gestational age was determined on the basis of last
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menstrual date and postnatally by Dubowitz scoring
scale (8). Urine samples were collected in sterile bags
within the first 48 hours of life, before the initiation
of aminoglycoside treatment and were stored at -20˚C.

Table 1.

Clinical data of infants studied on days 1-2.
Asphyxiated infants

Control infants

17

20

38.8 (38-40)

39.2 (38-41)

NS*

3400 (2600-3800)

3540 (2750-3950)

NS

Spontaneous (n)

7

9

NS

Caesarian section (n)

10

11

NS

At 1 minute

2.6 (0-6)

8.1 (7-1O)

<0.01

At 5 minutes

4.6 (2-7)

9.4 (8-10)

<0.01

n

Renal function tests consisted of monitoring
hourly urine excretion, urine osmolarity, asssessment
of serum urea and creatinine levels glomerular filtration rate (GFR=0,45 x Body length(cm)/ serum creatinine), urinary NAG excretion (U/L), NAG index (urinary NAG(U/dl) / urinary creatinine (mg/dl)) and
assessment of FeNa in infants who developed ARF. Oliguria (urine flow less than 1ml/kg/hour for at least
48 hours), serum creatinine level higher than 1.5 mg/
dl and FeNa greater than 3.5% were the criteria to
establish a diagnosis of renal paranchymal ARF (9,10).

Gestational age(weeks)

The study group was divided into two; group l
consisting of those with perinatal asphyxia without
ARF, group II consisting of those with prinatal asphyxia and ARF. Twenty healthy full-term infants without perinatal asphyxia and predisposition to tubulopathy comprised the control group.

* Non significant

Serum and urinary cratinine and sodium were
determined by autoanalyzer (Falcor-Menarini), and by
electrolyte analyzer (Spotlyte-Menarini) respectively.
Urinary NAG level was determined by colorimetric
method utilizing 3-cresolsulphaphytaleinyl-N-acetyl-β-Dglucosaminide as substrate to measure the level 3cresolsulphaphytalein sodium photometrically (Eppendorf photometer) at 580 nm (Boehringer-NAG,
Cat. No: 875406) (11).
Data were analysed using the Statistical Package
programe (Epistate). Significance was tested using Wilcoxon rank sum test and analysis of variance, differences between groups were tested using the least significant difference test at the 1% level.
Results
Clinical features of the study and control groups
were summarised on Table I. Study and control
groups were similar with regard to gestational age,
birth weight and mode of delivery.
Renal type ARF developed in 4 (23.5%) infants in
the study group at 2.8±0.5 days of life. None of
them needed peritoneal dialysis and all carried out
medical treatment.

Birth weight (g)

p Value

Mode of delivery:

Apgar score:

Seizures were observed in 7 infants with hypoxic-ischemic encephalopathy (HIE) in of whom ARF developed. Five (29.4%) infants presented with irritability, depression of neonatal reflexes and feeding
intolerance in 2 of whom ARF developed. Two infants
one with and one without ARF died at days 2 and 5
postnatally.
Biochemical data of the infants in the study group
is summarised on Table 2. Mean serum creatinine level
in group II was significantly higher than that in group
I in accordance with significantly lower GFR and hourly urine flow in group II (p<0.01) Mean urinary NAG
excretion of 17 infants with asphyxia was 27.75
±23.2 U/L (range 5.1-74.8) which was significantly
higher than that of the control group (1.61±0.22 U/L
(range 0.2-2.1)) (p<0.0001). NAG index, too, was
significantly higher in the study group (0.089 ± 0.062
U/mg creatinine (range 0.01-0.2) vs 0.0061 ±0.021
U/mg creatinine (range 0.001-0.0089); p<0.0001)(Table 2).
Urinary NAG excretion was 24.98 ±20.13 U/L
(range 5.1-74.8) in group I (without ARF) and 28.25
±29.31 U/L (range 6.3-70.6)in group I (with ARF)
which were statistically similar (p>0.05). NAG index
(0.081±0.058 U/mg creatinine (range 0.01-0.19) in
group I and 0.112 ±0.071 U/mg creatinine (range
0.041-0.2) in group II) was also statistically similar
between the study groups (p>0.05) (Table 2).
Discussion
Measurement of several tubular markers (retinolbinding protein, β2-microglobulin, myoglobinuria etc.)

72

M. AKISÜ, N. KÜLTÜRSAY, R. ORAL, N. TANSUĞ, C. KABASAKAL

Control infants

Asphyxiated infants

(n=20)

Group I (n=13)

Group II (n=4)

Serum creatinine
Concentration (mg/dl)

0.62 (0.4-0.9)

0.78 (0.5-1.1)

2.35(1.7-4.3)

Glomerular filtration

5.28(24.5-57.35)

31.34(2.45-46.8)

9.21(13.12-5.33

Not measured

Not measured

31(12-69)

Urine output (ml/kg/hour) Not measured

2.1 (1.5-2.7)

0.6 (0.3-0.8)

1.61 (0.2-2.1)

24.98 (5.1-74.8)

28.25 (6.3-70.6)

0.0061 (0.001-0.0089)

0.081 (0.01-0.19)

0.112 (0.041-0.2)

Table 2.

Results of biochemical tests in the
study group and control

2
rate (ml/min/1.73 M )

Fractional sodium
Excretion (%)

Urinary NAG
excretion (U/L)
NAG indeks (U/mg
creatinine)

NAG: N-acetyl-β-D-glucosaminidase

were found useful in diagnosis and follow-up of renal
failure. We aimed to explore the potential value of
NAG enzymuria to predict ARF that perinatal asphyxia
may cause.
Being a lysosomal enzyme, NAG, which is present
in several viscera other than kidney, is not filtered
across the glomerular membrane because of its high
molecular weight (130000-140000 daltons) (5). Since
it is more abundant in tubular cells compared to lower
urinary tract, increase in urinary excretion of NAG reflects renal tubular damage. NAG originating from other viscera is cleared from the circulation by the liver.
Urinary NAG excretion is a good indicator of neonatal
renal tubular function for the following reasons: Firstly, urinary NAG is completely of renal origin even if
glomerular permeability increases. Secondly, urine does
not include the inhibitors and activators of this enzyme. Thirdly there is no difference in the urinary levels between preterm (34-37 weeks) and full-term infants, and lastly urinary NAG excretion does not
decrease with aging during the neonatal period (5, 12,
13).
NAG enzymuria has been extensively used in evaluation of neonatal renal tubular function. Sheu et al
(14) investigated the effect of unconjugated hyperbilirubinemia on renal tubuli and Watanabe et al (15)
explored aminoglycoside nephrotoxicity by measuring
urinary NAG excretion.
Oxygen consumption of renal proximal tubular cells
is very high because of a great variety of functions
and subsequent high metablolic activity; that is why
tubular cells are very sensitive to both chronic and es-

pecially to acute hypoxia (1). Acute perinatal asphyxia
which may present with a wide spectrum of clinical
findings from simple meconium staining of the amniotic fluid to multiorgan failure is the major cause of renal tubular injury in neonates.
When proximal tubular cells which are rich in lysosomal due to their high metabolic rate are injured,
lysosomal NAG diffuses directly to the filtered urine
(12).
Mannarino et al measured amniotic NAG activity in
fetuses with chronic hypoxia and intravterine growth
retardation which was increased due to fetal tubular
injury (16). Csathy et al on the other hand showed
tubular injury in polycythemic neonates and premature
infants with respiratory distress syndrome by measuring increased urinary NAG excretion (17). Watanabe
et al were the first group to show increased NAG enzymuria in term infants with acute perinatal asphyxia
(18). Adamovich et al showed that NAG excretion decreased by day 7 in term and preterm infants with
perinatal asphyxia when treated with thyroxine which
improved renal functions (19). Chen et al showed increased NAG enzymuria in meconium stained infants
despite absence of neurologic symptoms and interpreted this increase as an indicator of mild perinatal
asphyxia (20). NAG enzymuria was significantly increased in infants with perinatal asphyxia in our study
group, be it associated with neurologic symptoms or
not. NAG enzymuria is a good indicator of proximal
tubular injury even in mild perinatal asphyxia.
Roberts et al showed that NAG enzymuria increased by 18 fold in term and preterm infants sur-
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viving perinatal asphyxia with ARF. This increase was
12 fold in those without ARF but they concluded that
even if NAG enzymuria is a specific indicator of tubular injury, it is not of great importance in either
early diagnosis of ARF or prediction of ARF development in perinatal asphyxia. They also showed that urinary excretion of retinol-binding protein and myoglobin was much more specific in early diagnosis of
ARF compared to NAG enzymuria (21). In concert
with Roberts’ findings, we also failed to show a statistically significant increase in NAG enzymuria in infants with perinatal asphyxia who subsequently developed ARF compared to those without ARF.

However NAG enzymuria of those with ARF was
somewhat higher than that of the group without ARF.
We also conclude that the level of NAG enzymuria is
not of great importance in predicting ARF development after hypoxic insult at an early stage. However,
NAG enzymuria is considered to be a very sensitive indicator of renal tubular damage even if decrase in
GFR as an indicator of ARF is not observed.
In conclusion we recommend that NAG may be
used as a marker of perinatal asphyxia and tubular
damage, since it is a good indicator of proximal tubular cell injury and readily masured in spot urine.
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